Page last updated: 2024-08-24

di-n-propyldithiocarbamate and Breast Cancer

di-n-propyldithiocarbamate has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, Y; Guo, R; Huang, T; Li, C; Li, X; Liu, Y; Wang, T; Yang, Y; Zhang, P; Zhang, Z; Zhou, P	1

Other Studies

1 other study(ies) available for di-n-propyldithiocarbamate and Breast Cancer

Article	Year
The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling. Scientific reports, 2018, 02-21, Volume: 8, Issue:1 Topics: Animals; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Ditiocarb; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Up-Regulation	2018

Article

Year

The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.

Scientific reports, 2018, 02-21, Volume: 8, Issue:1

Topics: Animals; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Ditiocarb; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Up-Regulation

2018